Panacea Biotec Limited has informed the Exchange about change in Management
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Panacea Biotec has informed the exchanges that Mr. Mohammed Shafiqur Rahman, Vice President – Regulatory Affairs and a designated Senior Management Personnel, has retired from the company on July 31, 2025 after 22 years of service. The exit is on account of superannuation, meaning it is a planned retirement and not a resignation, so no resignation letter has been filed. The disclosure has been made under SEBI LODR Regulation 30 with details attached as Annexure A. The communication is signed by Vinod Goel, Group CFO, Head Legal and Company Secretary. There is no change in any director, CEO, CFO or other Key Managerial Personnel.
This is a routine, planned retirement of a senior executive after a long tenure and is unlikely to have any material impact on the company's operations or stock price. No leadership vacuum at the board or KMP level is created.